These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4943575)

  • 1. Folate inhibitors: a structure-activity analysis using linear modeling.
    Hansch C
    Ann N Y Acad Sci; 1971 Nov; 186():235-47. PubMed ID: 4943575
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative correlation between molar refractivity and the inhibition of dihydrofolate reductase by 2,4-diamino-5-benzylpyrimidines.
    Kumar NA; Rao MN
    Indian J Biochem Biophys; 1986 Feb; 23(1):58-60. PubMed ID: 3525396
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-(1-Adamantyl) pyrimidines as inhibitors of folate metabolism.
    Ho YK; Hakala MT; Zakrzewski SF
    Cancer Res; 1972 May; 32(5):1023-8. PubMed ID: 4552913
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the inhibition of bovine and murine leukemia dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-X-phenyl)-s-triazines.
    Guo ZR; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    Mol Pharmacol; 1981 Nov; 20(3):649-56. PubMed ID: 7329407
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential binding to the hydrophobic bonding region of T2 phage induced, Escherichia coli B, and pigeon liver dihydrofolic reductases.
    Baker BR
    J Med Chem; 1967 Sep; 10(5):912-7. PubMed ID: 4860445
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to substituted pyrimidines, triazines and MTX.
    Smith CC; Freisheim JH
    Ann N Y Acad Sci; 1971 Nov; 186():182-4. PubMed ID: 5002296
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonlinear quantitative structure-activity relationship for the inhibition of dihydrofolate reductase by pyrimidines.
    Hirst JD
    J Med Chem; 1996 Aug; 39(18):3526-32. PubMed ID: 8784450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).
    Seydel JK; Richter M; Wempe E
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):18-29. PubMed ID: 6988345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
    Dietrich SW; Blaney JM; Reynolds MA; Jow PY; Hansch C
    J Med Chem; 1980 Nov; 23(11):1205-12. PubMed ID: 7005446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic studies of the reaction mechanism of dihydrofolate reductase.
    Blakley RL; Schrock M; Sommer K; Nixon PF
    Ann N Y Acad Sci; 1971 Nov; 186():119-30. PubMed ID: 4399848
    [No Abstract]   [Full Text] [Related]  

  • 12. Engineering specificity for folate into dihydrofolate reductase from Escherichia coli.
    Posner BA; Li L; Bethell R; Tsuji T; Benkovic SJ
    Biochemistry; 1996 Feb; 35(5):1653-63. PubMed ID: 8634297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of inhibitory effects of triazines on dihydrofolate reductase isolated from murine leukemia cells with the inhibition of growth of cells in culture].
    Guo ZG
    Yao Xue Xue Bao; 1983 Feb; 18(2):125-9. PubMed ID: 6613591
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationships of dihydrofolate reductase inhibitors.
    Bowden K; Harris NV; Watson CA
    J Chemother; 1993 Dec; 5(6):377-88. PubMed ID: 8195829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible enzyme inhibitors. CV. Differential irreversible inhibition of vertebrate dihydrofolic reductases by derivatives of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazines substituted with a terminal sulfonyl fluoride.
    Baker BR; Lourens GJ
    J Med Chem; 1967 Nov; 10(6):1113-22. PubMed ID: 6056040
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of bovine and rat liver dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(4-substituted-phenyl)-s-triazines.
    Hansch C; Dietrich SW; Fukunaga JY
    J Med Chem; 1981 May; 24(5):544-9. PubMed ID: 7241512
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
    Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ
    J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.
    Gangjee A; Guo X; Queener SF; Cody V; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Apr; 41(8):1263-71. PubMed ID: 9548816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action of site-directed irreversible folate analogue inhibitors of thymidylate synthase.
    Lobo AP; Nair MG; Changchien L; Weichsel A; Montfort WR; Maley F
    Biochemistry; 1998 Mar; 37(13):4535-42. PubMed ID: 9521774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.